anticoronavir
activ
mixtur
oleoresin
essenti
oil
botan
design
examin
vitro
vivo
treatment
avian
infecti
bronchiti
viru
ibv
reduc
viru
titer
measur
two
laboratori
host
system
vero
cell
embryon
egg
effect
ibv
chicken
also
investig
administ
chicken
dilut
spray
h
challeng
ibv
determin
effect
treatment
treatment
decreas
sever
clinic
sign
lesion
bird
lower
amount
viral
rna
trachea
treatment
protect
chicken
day
posttreat
clinic
sign
diseas
infect
decreas
transmiss
ibv
period
antiibv
activ
greater
prior
viru
attach
entri
indic
effect
virucid
addit
activ
massachusett
arkansa
type
ib
virus
indic
expect
effect
ibv
regardless
serotyp
knowledg
first
report
vivo
use
virucid
mixtur
compound
effect
coronaviru
ibv
avian
infecti
bronchiti
viru
ibv
coronaviru
caus
highli
contagi
upperrespiratori
tract
diseas
chicken
also
found
speci
bird
includ
peafowl
pavo
spp
teal
ana
crecca
cavanagh
viru
worldwid
distribut
caus
huge
econom
loss
poultri
industri
result
reduct
feed
convers
weight
gain
condemn
process
plant
cavanagh
gelb
loss
also
due
drop
egg
product
poor
egg
qualiti
layer
type
chicken
strain
viru
nephropathogen
extens
mortal
occur
cavanagh
gelb
infecti
bronchiti
viru
present
uniqu
challeng
regard
control
commerci
chicken
genom
divers
abbrevi
cpe
cytopath
effect
embryo
infecti
dose
elisa
enzym
link
immunosorb
assay
hma
hexamethylen
amilorid
ibv
infecti
bronchiti
viru
mhv
mous
hepat
viru
pb
phosphat
buffer
salin
rflp
restrict
fragment
length
polymorph
rtpcr
revers
transcriptasepolymeras
chain
reaction
sarscov
sever
acut
respiratori
syndrom
viru
spf
specif
pathogen
free
tissu
cultur
infecti
dose
correspond
author
tel
fax
email
address
mjackwoo
ugaedu
mw
jackwood
abil
ibv
rapidli
chang
creat
differ
serotyp
viru
cross
protect
cavanagh
gelb
consequ
attenu
live
vaccin
use
control
diseas
must
select
specif
serotyp
ibv
present
flock
compound
situat
presenc
serolog
differ
variant
strain
vaccin
exist
interest
explor
altern
method
control
ibv
could
potenti
effect
across
serotyp
antivir
compound
use
target
protein
involv
coronavir
replic
coronavirus
singl
strand
posit
sens
rna
genom
approxim
kb
length
ibv
coronaviru
replic
nest
set
subgenom
viral
mrna
produc
viral
rnadepend
rnapolymeras
four
structur
protein
translat
envelop
viru
spike
envelop
membran
nucleocapsid
cavanagh
gelb
two
larg
gene
genom
viral
rna
encod
viralrepl
complex
gene
translat
polyprotein
process
main
proteas
pro
well
papainlik
proteas
form
viral
polymeras
associ
nonstructur
protein
ziebuhr
et
al
main
proteas
coronavirus
appear
attract
target
antivir
compound
haagman
osterhau
niu
et
al
xue
et
al
yang
et
al
yang
et
al
inhibitor
pro
includ
michael
acceptor
inhibitor
design
chloromethyl
keton
epoxid
inhibitor
shown
effect
rhinoviru
pro
homolog
anand
et
al
niu
et
al
xue
et
al
antivir
compound
like
hexamethylen
amilorid
hma
target
ion
channel
conduct
shown
antivir
effect
human
coronaviru
hcov
mous
hepat
viru
mhv
coronaviru
vitro
wilson
et
al
addit
specif
inhibit
ibv
report
vitro
use
lithium
chlorid
harrison
et
al
howev
lithium
chlorid
toxin
use
antivir
ibv
vivo
remain
determin
major
problem
surround
antivir
compound
target
specif
viral
gene
protein
abil
viru
rapidli
mutat
replic
becom
resist
exampl
includ
acyclovir
resist
human
immunodefici
virus
herp
simplex
virus
mcmahon
et
al
oseltamivir
resist
influenza
virus
collin
et
al
nucleosidenucleotid
analog
resist
hepat
b
virus
delaney
borrotoesoda
altern
compound
virucid
effect
work
like
disinfect
requir
replic
inactiv
viru
reichl
et
al
schuhmach
et
al
thu
resist
virucid
compound
due
mutat
gener
viral
genom
replic
unlik
schnitzler
et
al
virucid
activ
essenti
oil
botan
report
number
virus
includ
herp
simplex
viru
dengu
viru
junin
viru
duschatzki
et
al
koch
et
al
schnitzler
et
al
virucid
activ
essenti
oil
lipophil
natur
probabl
due
disrupt
viral
membran
interfer
viral
envelop
protein
involv
host
cell
attach
although
select
resist
mutant
possibl
report
inactiv
viru
lipophil
essenti
oil
time
depend
infecti
viru
remain
treatment
still
sensit
essenti
oil
make
select
resist
mutant
unlik
schnitzler
et
al
studi
examin
effect
natur
base
product
consist
synergist
blend
botan
oleoresin
essenti
oil
liquid
emuls
design
ibv
vitro
vivo
knowledg
first
report
virucid
activ
botan
extract
coronaviru
vivo
data
import
type
compound
might
also
use
control
coronavirus
like
sever
acut
respiratori
syndrom
coronaviru
sarscov
well
envelop
virus
like
avian
influenza
viru
newcastl
diseas
viru
strain
ibv
use
studi
vero
cell
adapt
beaudett
strain
american
type
cultur
collect
atcc
rockvil
md
pathogen
massachusett
strain
atcc
arkansa
dpi
arkdpi
vaccin
strain
intervet
scheringplough
anim
health
millsboro
de
beaudett
strain
ibv
propag
vero
cell
arkdpi
strain
ibv
propag
inject
chorioallanto
sac
specif
pathogen
free
spf
embryon
chicken
egg
sunris
farm
inc
catskil
ny
use
standard
method
gelb
jackwood
vero
cell
obtain
american
type
cultur
collect
rockdal
md
propag
minimum
essenti
medium
eagl
mm
lglutamin
gl
sodium
bicarbon
mm
nonessenti
amino
acid
mm
sodium
pyruv
fetal
bovin
serum
invitrogen
corp
gibco
carlsbad
ca
c
co
rna
extract
realtim
rtpcr
ibv
viral
rna
extract
rna
isol
kit
ambion
inc
austin
tx
accord
manufactur
protocol
use
kingfish
magnet
particl
processor
thermo
scientif
waltham
realtim
rtpcr
conduct
use
smart
cycler
ii
cepheid
sunnyval
ca
agpathid
tm
onestep
rtpcr
kit
ambion
inc
accord
manufactur
recommend
realtim
rtpcr
primer
probe
previous
publish
callison
et
al
consist
forward
primer
gct
ttt
gag
cct
agc
revers
primer
gcc
atg
ttg
tca
ctg
tct
att
taqman
duallabl
probe
g
probe
famcac
cac
cag
aac
ctg
tca
cct
rtpcr
primer
synthes
integr
dna
technolog
coralvil
ia
taqman
probe
obtain
biosearch
technolog
novato
ca
compon
realtim
rtpcr
test
thermocycl
paramet
previous
describ
standard
curv
assay
use
calcul
approxim
genom
copi
number
sampl
callison
et
al
chick
hatch
spf
fertil
leghorn
chicken
egg
sunris
farm
inc
poultri
diagnost
research
center
colleg
veterinari
medicin
univers
georgia
athen
ga
meattyp
commerci
broiler
chicken
obtain
harrison
poultri
bethlehem
ga
experi
chick
randomli
divid
differ
group
hous
positivepressur
horsfal
isol
unit
litter
coloni
hous
feed
water
given
ad
libitum
experi
describ
design
determin
effect
obtain
quigley
pharma
inc
subsidiari
quigley
corpor
doylestown
pa
ibv
vitro
vivo
synergist
blend
botan
oleoresin
essenti
oil
liquid
emuls
pharmaceut
grade
excipi
exact
composit
avail
quigley
pharma
inc
toxic
vero
cell
embryon
egg
examin
minimum
effect
dose
ibv
propag
laboratori
system
determin
vero
cell
grown
confluenc
flask
bd
bioscienc
franklin
lake
nj
transfer
two
plate
bd
bioscienc
cell
reach
confluenc
media
remov
l
undilut
dilut
diluent
quigley
pharma
inc
prepar
cell
cultur
mainten
medium
contain
fetal
bovin
serum
ad
differ
well
control
well
receiv
cell
cultur
mainten
medium
also
includ
experi
cell
incub
day
c
co
examin
twice
daili
cytopath
effect
cpe
experi
repeat
time
specif
pathogen
free
fertil
chicken
egg
obtain
sunris
farm
catskil
ny
incub
c
day
embryon
egg
inocul
chorioallanto
sac
l
undilut
dilut
diluent
prepar
pb
ph
four
egg
inocul
dilut
experi
repeat
time
neg
control
egg
receiv
pb
also
includ
egg
incub
c
candl
daili
day
record
mortal
mortal
occur
within
first
h
consid
due
trauma
associ
inocul
disregard
day
remain
egg
chill
c
open
examin
embryo
clinic
sign
toxic
test
effect
ibv
propag
vero
cell
constant
amount
viru
tissu
cultur
infecti
dose
tcid
beaudett
strain
ibv
ad
seven
serial
dilut
begin
dilut
determin
nontox
vero
cell
diluent
prepar
cell
cultur
mainten
medium
mixtur
incub
room
temperatur
min
nine
serial
dilut
mainten
medium
mixtur
prepar
inocul
onto
cell
cell
cultur
media
remov
cell
tissu
cultur
plate
mixtur
inocul
onto
monolay
neg
control
well
receiv
cell
cultur
mainten
medium
also
includ
experi
cell
incub
day
c
co
examin
twice
daili
cytopath
effect
cpe
experi
repeat
time
experiment
design
test
effect
ibv
grown
embryon
egg
except
begin
concentr
diluent
undilut
sinc
neither
compound
toxic
embryo
constant
amount
viru
embryo
infecti
dose
eid
ibv
beaudett
strain
mix
undilut
dilut
diluent
prepar
pb
neg
control
egg
receiv
pb
also
includ
mixtur
incub
room
temperatur
min
nine
serial
dilut
pb
mixtur
prepar
l
dilut
inocul
chorioallanto
sac
four
egg
inocul
dilut
incub
c
candl
daili
day
record
mortal
sinc
mortal
occur
within
first
h
could
due
trauma
associ
inocul
disregard
day
remain
egg
chill
c
open
examin
embryo
lesion
eid
titer
calcul
reed
muench
method
villega
experi
repeat
time
twoweekold
spf
leghorn
chicken
divid
group
bird
hous
horsfal
isol
unit
undilut
compound
given
intranas
l
per
bird
spray
ml
per
bird
drink
water
ml
mix
equal
volum
reconstitut
nonfat
dri
milk
per
bird
h
water
starvat
promot
drink
spray
deliv
preval
sprayer
precis
valv
corp
yonker
ny
block
fresh
air
deliveri
isol
preval
spray
applic
consist
ml
refil
reservoir
compress
air
power
unit
although
directli
measur
averag
particl
size
type
sprayer
rang
would
deposit
nasooropharyngolaryng
region
respiratori
tract
phalen
mendez
spray
treatment
last
approxim
fresh
air
resum
min
follow
treatment
deliveri
method
administ
bird
either
h
challeng
h
challeng
h
challeng
two
nontreat
group
bird
serv
challeng
control
nonchalleng
neg
control
treat
bird
one
nontreat
group
challeng
eid
pathogen
strain
ibv
per
bird
challeng
viru
given
intranas
bird
examin
twice
daili
clinic
sign
diseas
day
postchalleng
bird
kill
necropsi
necropsi
tracheal
swab
collect
place
ice
cold
pb
presenc
viru
determin
extract
rna
directli
pb
quantit
realtim
rtpcr
conduct
rna
clinic
sign
gross
lesion
record
trachea
harvest
histopatholog
clinic
sign
score
follow
normal
wateri
eye
mucu
nare
wateri
eye
mucu
nare
wateri
eye
mucu
nare
tracheal
rale
trachea
collect
neutral
buffer
formalin
routin
process
paraffin
section
cut
hematoxylin
eosin
stain
epitheli
hyperplasia
lymphocyt
infiltr
sever
epitheli
decili
score
trachea
normal
sever
experi
spf
leghorn
chicken
divid
group
bird
hous
horsfal
isol
unit
half
bird
treat
h
challeng
half
treat
h
challeng
bird
treat
either
undilut
serial
dilut
start
dilut
dilut
dilut
prepar
steril
distil
deioniz
water
mlbird
deliv
via
spray
preval
sprayer
precis
valv
corp
describ
experi
addit
control
group
bird
includ
experi
bird
treat
challeng
challeng
control
group
bird
treat
spray
rout
undilut
challeng
bird
treat
challeng
neg
control
group
treat
bird
unless
otherwis
indic
one
nontreat
group
challeng
eid
pathogen
strain
ibv
per
bird
describ
experi
bird
examin
clinic
sign
necropsi
day
postchalleng
describ
experi
clinic
sign
score
describ
experi
commerci
broiler
chicken
vaccin
divid
differ
group
hous
horsfal
isol
unit
serum
collect
sever
bird
begin
experi
determin
level
matern
antibodi
ibv
antibodi
detect
use
commerci
enzym
link
immunosorb
assay
elisa
test
idexx
inc
westbrook
bird
treat
dilut
steril
distil
deioniz
water
spray
preval
sprayer
precis
valv
corp
challeng
eid
strain
ibv
h
h
day
day
day
day
treatment
bird
challeng
intranas
describ
experi
control
includ
bird
treat
challeng
time
neg
group
treat
challeng
bird
challeng
h
necropsi
day
day
challeng
along
one
nontreatednonchalleng
control
group
bird
challeng
day
treatment
necropsi
along
neg
nonchalleng
control
group
day
challeng
time
bird
score
clinic
sign
necropsi
describ
experi
commerci
broiler
chicken
vaccin
equal
divid
hous
two
coloni
hous
pine
shave
floor
coloni
hous
use
adequ
number
bird
could
maintain
togeth
transmiss
experi
mimic
close
possibl
commerci
chicken
hous
condit
week
age
bird
hous
remov
wingband
futur
identif
given
full
dose
modifi
live
ibv
arkansa
type
vaccin
eye
accord
manufactur
recommend
intervet
scheringplough
anim
health
millsburo
de
bird
held
isol
h
reintroduc
back
coloni
hous
immedi
reintroduc
bird
coloni
hous
bird
one
hous
treat
spray
use
preval
sprayer
precis
valv
corp
ml
dilut
steril
deionizeddistil
water
per
bird
monitor
transmiss
viru
contact
expos
bird
remov
swab
trachea
bird
day
posttreat
also
remov
swab
bird
given
vaccin
sampl
time
bird
swab
remov
experi
avoid
promot
spread
viru
induc
damag
trachea
prevent
swab
bird
twice
experi
viru
detect
tracheal
swab
determin
realtim
rtpcr
serum
collect
bird
begin
experi
week
age
determin
level
matern
antibodi
ibv
addit
collect
sera
bird
n
necropsi
last
day
experi
test
antibodi
ibv
newcastl
diseas
viru
infecti
bursal
diseas
viru
antibodi
test
use
commerci
elisa
test
idexx
inc
viru
titer
calcul
method
reed
muench
villega
mean
standard
deviat
calcul
ct
valu
analyz
statist
student
ttest
histopatholog
score
analyz
kruskalw
test
coupl
dunn
posttest
transmiss
experi
data
analyz
fisher
exact
test
use
jmp
statist
discoveri
softwar
sa
institut
inc
cari
nc
experi
toxic
cell
cultur
embryon
egg
effect
ibv
vitro
undilut
dilut
toxic
vero
cell
cell
inocul
dilut
cpe
affect
monolay
cell
inocul
dilut
higher
unaffect
day
posttreat
vero
cell
inocul
undilut
dilut
diluent
cpe
cell
wherea
cell
inocul
higher
dilut
diluent
cpe
follow
day
incub
none
neg
control
cell
cpe
disregard
embryo
death
within
h
inocul
none
embryon
egg
die
cours
experi
day
posttreat
none
embryo
receiv
embryo
receiv
diluent
gross
lesion
expect
none
neg
control
embryo
lesion
determin
decreas
titer
infecti
viru
examin
effect
ibv
beaudett
strain
determin
titrat
vero
cell
data
present
fig
treatment
dilut
reduc
titer
ibv
averag
tcid
ml
treatment
dilut
reduc
ibv
titer
tcid
ml
none
dilut
higher
reduc
titer
ibv
reduct
viru
titer
observ
diluent
dilut
none
cell
neg
control
well
cell
cultur
mainten
medium
alon
cpe
data
shown
data
show
effect
ibv
beaudett
strain
determin
titrat
embryon
egg
also
measur
decreas
infecti
viru
data
present
fig
titrat
ibv
beaudett
strain
vero
cell
follow
treatment
serial
dilut
start
cell
cultur
mainten
medium
cell
cultur
mainten
medium
plu
ibv
alon
control
present
tissu
cultur
infecti
dose
titer
reflect
averag
three
replic
reduct
viru
titer
observ
ibv
treat
diluent
data
shown
fig
treatment
undilut
reduc
titer
ibv
eid
ml
dilut
reduc
titer
ibv
eid
ml
respect
reduct
ibv
titer
observ
dilut
use
diluent
dilut
use
lesion
embryo
typic
report
ibv
gelb
jackwood
clinic
sign
observ
viru
challeng
group
bird
regardless
treatment
intranas
spray
treat
group
fewer
bird
sign
sign
milder
reflect
lower
averag
score
tabl
viru
detect
bird
treat
intranas
rout
h
challeng
viru
detect
intranas
treatment
fig
titrat
ibv
beaudett
strain
embryon
egg
follow
treatment
serial
dilut
start
dilut
pb
pb
plu
ibv
control
present
embryo
infecti
dose
titer
reflect
averag
two
replic
reduct
viru
titer
observ
ibv
treat
diluent
data
shown
clinic
sign
viru
detect
spf
chicken
follow
treatment
ibv
challeng
water
h
challeng
water
h
challeng
water
h
challeng
challeng
control
g
neg
control
h
neg
b
bird
intranas
challeng
embryo
infecti
pathogen
ibv
strain
b
clinic
sign
record
day
follow
challeng
score
follow
normal
wateri
eye
mucu
nare
wateri
eye
mucu
nare
wateri
eye
mucu
nare
tracheal
rale
c
viru
detect
directli
tracheal
swab
collect
day
follow
challeng
realtim
rtpcr
averag
cycl
threshold
ct
valu
posit
sampl
calcul
indic
rel
amount
viru
detect
trachea
higher
number
less
viru
e
averag
histopatholog
score
bird
clinic
sign
base
epitheli
hyperplasia
lymphocyt
infiltr
epitheli
decili
normal
sever
number
differ
superscript
statist
differ
kruskalw
test
p
f
neg
g
challeng
control
bird
treat
challeng
h
neg
control
bird
treat
challeng
group
spray
treat
group
clinic
sign
observ
bird
treat
water
clinic
sign
score
higher
intranas
spray
treat
bird
viru
detect
one
bird
h
challeng
group
see
tabl
receiv
water
sever
clinic
sign
observ
viru
detect
ibv
challeng
bird
receiv
treatment
addit
neg
control
bird
remain
neg
clinic
sign
viru
detect
trachea
score
describ
section
normal
sever
bird
receiv
challeng
viru
averag
lesion
score
histopatholog
score
treat
challeng
bird
clinic
sign
statist
differ
nonchalleng
control
challeng
control
p
bird
clinic
sign
regardless
group
statist
differ
neg
control
bird
data
shown
dose
respons
observ
bird
treat
h
viru
challeng
fig
less
pronounc
respons
observ
bird
treat
h
viru
challeng
viru
detect
trachea
challeng
bird
treatment
lower
dilut
h
challeng
pronounc
effect
lower
amount
viru
detect
trachea
gener
clinic
sign
sever
involv
bird
higher
dilut
see
averag
score
tabl
trachea
score
describ
section
normal
sever
bird
given
undilut
score
normal
averag
score
statist
lower
p
lesion
score
tabl
observ
dilut
lower
administ
spray
treatment
h
challeng
spray
treatment
statist
lower
tracheal
tabl
experi
dose
titrat
spray
treatment
specif
pathogen
free
chicken
h
h
challeng
pathogen
ibv
lesion
score
given
h
challeng
bird
treat
receiv
challeng
viru
averag
tracheal
lesion
score
ten
bird
bled
day
age
expect
nonvaccin
commerci
broiler
posit
matern
antibodi
ibv
averag
titer
elisa
idexx
laboratori
number
bird
show
clinic
sign
ibv
infect
averag
clinic
sign
score
shown
tabl
number
bird
clinic
sign
treat
challeng
within
day
treatment
rang
bird
challeng
day
treatment
bird
clinic
sign
sampl
day
observ
bird
day
nontreat
challeng
control
group
clinic
sign
indic
matern
antibodi
prevent
diseas
none
nonchalleng
bird
clinic
sign
gener
clinic
sign
treat
challeng
bird
consist
wateri
eye
mucu
nare
occasion
bird
sign
unlik
vaccin
reaction
consid
extrem
mild
evidenc
averag
clinic
sign
score
comparison
nontreat
challeng
bird
sever
sign
consist
wateri
eye
mucu
nare
swollen
sinus
excess
mucu
trachea
result
tracheal
rale
challeng
viru
detect
challeng
bird
even
treat
bird
tabl
indic
protect
infect
although
data
statist
differ
treat
bird
challeng
h
h
day
day
day
day
fewer
viral
genom
copi
nontreat
challeng
group
time
respect
viru
detect
trachea
bird
challeng
trachea
score
describ
section
normal
sever
bird
receiv
challeng
viru
normal
averag
score
tabl
bird
challeng
appreci
lesion
trachea
tracheal
lesion
score
nonchalleng
bird
treat
statist
differ
nontreat
nonchalleng
bird
p
tracheal
lesion
score
treat
challeng
group
statist
higher
nonchalleng
bird
high
nontreat
challeng
bird
p
posit
control
nontreat
challeng
bird
tracheal
lesion
score
statist
higher
group
p
viru
detect
bird
vaccin
arkansa
type
ibv
day
postinfect
fig
viru
detect
vaccin
bird
treat
group
day
postvaccin
tabl
experi
clinic
sign
broiler
chicken
challeng
ibv
variou
time
treatment
day
age
clinic
sign
consist
wateri
eye
tracheal
rale
mucu
nare
trachea
b
bird
given
strain
ibv
intranas
c
number
bird
clinic
sign
per
total
averag
score
clinic
sign
score
follow
normal
wateri
eye
mucu
nare
wateri
eye
mucu
nare
wateri
eye
mucu
nare
tracheal
rale
averag
score
differ
capit
letter
superscript
statist
signific
p
kruskalw
test
clinic
sign
score
neg
control
bird
normal
bird
necropsi
day
postchalleng
trachea
collect
neutral
buffer
formalin
routin
process
stain
see
section
score
epitheli
hyperplasia
lymphocyt
infiltr
epitheli
decili
normal
sever
score
differ
capit
letter
superscript
statist
signific
kruskalw
test
p
b
bird
receiv
challeng
viru
given
strain
ibv
intranas
vaccin
bird
treat
nontreat
group
respect
day
postinfect
transmiss
ibv
vaccin
contact
expos
bird
monitor
detect
viru
trachea
use
realtim
rtpcr
percent
contact
expos
bird
posit
ibv
present
fig
treat
group
viru
detect
contact
expos
bird
day
postexposur
nontreat
group
bird
posit
day
postexposur
day
postexposur
contact
expos
bird
posit
treat
group
wherea
bird
posit
nontreat
group
day
postexposur
contact
expos
treat
bird
posit
viru
contrast
nontreat
group
contact
expos
bird
posit
day
postexposur
data
statist
differ
day
p
day
postexposur
serum
collect
nonvaccin
commerci
broiler
day
age
bird
bled
experi
averag
matern
antibodi
titer
ibv
antibodi
ibv
detect
elisa
n
week
age
bird
vaccin
serum
collect
bird
necropsi
end
experi
none
bird
posit
antibodi
ibv
none
posit
antibodi
ndv
two
bird
treat
contact
group
posit
ibdv
averag
titer
virucid
activ
essenti
oil
lipophil
natur
like
act
disrupt
viral
membran
interfer
viral
envelop
protein
involv
host
cell
attach
schuhmach
et
al
report
examin
effect
natur
base
product
consist
synergist
blend
botan
oleoresin
essenti
oil
liquid
emuls
design
ibv
minimum
effect
concentr
ibv
determin
vitro
use
beaudett
strain
ibv
adapt
grow
cell
cultur
optim
rout
time
administr
effect
dose
durat
effect
ibv
chicken
investig
use
widespread
pathogen
strain
viru
arkansa
vaccin
type
virus
frequent
found
circul
commerci
chicken
flock
jackwood
et
al
also
examin
effect
transmiss
modifi
live
arkansa
type
ibv
vaccin
broiler
chicken
lowest
dilut
caus
toxic
effect
vero
cell
capabl
reduc
titer
ibv
tcid
ml
undilut
toxic
embryon
egg
reduc
titer
ibv
eid
ml
diluent
reduc
titer
indic
oleoresin
essenti
oil
respons
effect
next
sought
determin
effect
biolog
signific
chicken
infect
ibv
posit
neg
control
group
includ
vivo
studi
howev
includ
diluent
control
group
first
experi
diluent
shown
effect
viru
titer
base
clinic
sign
lesion
viru
detect
best
rout
administr
determin
intranas
spray
inocul
h
challeng
addit
appear
treatment
intranas
spray
h
challeng
somewhat
better
intranas
spray
treatment
h
challeng
administr
water
littl
effect
regardless
treatment
time
base
microscop
lesion
appear
alon
advers
affect
epithelium
trachea
interest
could
detect
viru
group
treat
intranas
spray
experi
appear
reduc
titer
ibv
infecti
threshold
infect
often
occur
bird
challeng
eid
strain
ibv
jackwood
unpublish
data
also
possibl
inhibitor
realtim
rtpcr
reaction
prevent
detect
howev
abl
detect
challeng
viru
group
suggest
presenc
inhibitor
inconsist
anoth
explan
like
sinc
spray
suitabl
mass
applic
commerci
chicken
use
rout
administr
examin
minimum
effect
dose
durat
activ
effect
transmiss
ibv
chicken
bird
treat
spray
h
challeng
show
clear
dose
respons
undilut
dilut
tabl
fig
treatment
h
challeng
less
pronounc
dose
respons
indic
less
effect
follow
viru
attach
entri
host
cell
data
time
administr
data
suggest
activ
virucid
rather
antivir
natur
onedayold
broiler
chicken
treat
protect
clinic
sign
diseas
follow
challeng
pathogen
ibv
day
posttreat
tabl
although
matern
antibodi
chick
gener
last
week
age
provid
protect
ibv
mondal
naqi
observ
clinic
sign
nontreat
viru
challeng
control
bird
indic
matern
antibodi
play
role
protect
clinic
sign
protect
infect
observ
sinc
challeng
viru
detect
treat
challeng
bird
howev
two
challeng
time
h
amount
challeng
viru
trachea
slightli
lower
treat
group
valu
statist
signific
previou
studi
differ
amount
ibv
given
chicken
report
amount
viru
detect
clinic
sampl
trachea
correl
dose
day
postchalleng
day
postchalleng
bird
similar
level
viru
trachea
regardless
challeng
dose
callison
et
al
treatment
may
lower
amount
viru
bird
day
postchalleng
collect
sampl
littl
differ
viral
load
observ
examin
bird
day
postchalleng
usda
recommend
procedur
usda
aphi
titl
code
feder
regul
http
wwwaccessgpogovnaracfrwaisidx
evalu
protect
ibv
challeng
sinc
challeng
viru
detect
trachea
treat
bird
possibl
clinic
sign
would
observ
treat
bird
observ
beyond
day
postchalleng
also
possibl
fewer
clinic
sign
would
observ
bird
beyond
day
postchalleng
sinc
delay
clinic
sign
may
repres
addit
time
bird
mount
protect
immun
respons
challeng
viru
protect
broiler
chicken
day
posttreat
clinic
sign
diseas
infect
may
provid
opportun
induc
level
local
immun
due
presenc
challeng
viru
although
measur
local
immun
studi
protect
bird
sever
upperrespiratori
diseas
time
allow
field
virus
infect
induc
immun
respons
may
provid
mechan
specif
protect
chicken
resid
field
viru
es
regardless
viru
type
transmiss
arkansa
type
ibv
vaccin
infect
contact
control
pen
mate
examin
observ
nontreat
contact
expos
bird
posit
ibv
wherea
treat
contact
expos
bird
posit
viru
day
postexposur
clearli
treatment
diminish
transmiss
ibv
contact
expos
bird
effect
statist
signific
p
ensur
matern
antibodi
play
role
experi
vaccin
bird
week
age
matern
antibodi
longer
detect
previous
report
studi
shown
arkansa
type
vaccin
preval
viru
commerci
broiler
capabl
persist
flock
jackwood
et
al
mckinley
et
al
nix
et
al
van
santen
toro
vaccin
viru
use
experi
coloni
hous
necessari
hous
number
bird
need
experi
biolog
secur
prevent
us
use
pathogen
isol
ibv
although
experi
design
model
prevent
spread
pathogen
ibv
isol
data
directli
address
extrem
import
problem
arkansa
vaccin
viru
persist
commerci
broiler
flock
persist
ibv
flock
caus
sever
vaccin
reaction
provid
opportun
vaccin
viru
mutat
revert
pathogen
well
chang
antigen
avoid
immun
respons
bird
reduct
transmiss
afford
treatment
extrem
import
sinc
limit
ibv
transmiss
flock
like
lessen
even
prevent
persist
arkansa
vaccin
viru
flock
sinc
effect
pathogen
strain
ibv
expect
also
limit
transmiss
pathogen
field
strain
ibv
commerci
broiler
therebi
decreas
sever
diseas
first
report
use
mixtur
natur
ingredi
specif
botan
oleoresin
essenti
oil
control
measur
ibv
mass
deliveri
spray
compat
applic
commerci
set
effect
mass
ark
type
ib
virus
indic
ought
effect
ibv
regardless
serotyp
effect
appear
pronounc
cell
free
viru
indic
activ
like
virucid
import
may
also
effect
envelop
respiratori
virus
like
avian
influenza
viru
newcastl
diseas
viru
commerci
poultri
well
coronavirus
anim
human
addit
sinc
virucid
compound
work
inactiv
virus
rather
target
specif
viru
gene
protein
reduc
likelihood
resist
develop
mutat
viru
replic
